Target intelligence / Profile preview

BEN domain containing 3 pseudogene 1 (BEND3P1)

Target
BEND3P1
Molecular classification
Other (pseudogene)
01

Overview

BEN domain containing 3 pseudogene 1 (BEND3P1) is annotated as a human pseudogene species: BEND3P1 (Gene ID: 644459)[2][5]. Pseudogenes are generally classified as non-functional genomic elements derived from protein-coding genes through duplication or retrotransposition and usually do not encode active proteins[6]. BEND3P1 is homologous to BEN domain containing 3 (BEND3), a functional gene that encodes a transcriptional repressor with multiple BEN domains, known to mediate chromatin interactions and regulate transcription[1][3]. There is no credible scientific evidence that BEND3P1 directly encodes a functional gene product, acts as a therapeutic target, or interacts with known drugs. It is not described as a receptor, enzyme, transporter, transcription factor, or signaling molecule, and there is no information associating it with disease involvement or biomarker status. BEND3P1 can be distinguished from BEND3, which is a bona fide chromatin regulator and CpG island-binding protein involved in transcriptional repression during differentiation[1][3]. The designation "pseudogene" means BEND3P1 is typically considered non-functional, not a classical molecular target, and is not pursued in drug discovery or as a diagnostic marker. If detailed molecular target information is required, refer to BEND3 (BEN domain containing 3). In summary, BEND3P1 is mostly an annotated pseudogene of scientific record, not a druggable or functional target.

Other names
BEN domain containing 3 pseudogene 1

Beyond the preview

Go deeper on BEN domain containing 3 pseudogene 1 (BEND3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BEN domain containing 3 pseudogene 1 (BEND3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call